透皮
医学
重症监护医学
临床试验
不利影响
药物输送
免疫抑制
移植
生物材料
风险分析(工程)
药理学
外科
生物医学工程
纳米技术
病理
免疫学
材料科学
作者
Ashish Dhayani,Sanjeeb Kalita,Manohar Mahato,Preethem Srinath,Praveen Kumar Vemula
出处
期刊:Nanomedicine
[Future Medicine]
日期:2019-10-01
卷期号:14 (20): 2713-2733
被引量:13
标识
DOI:10.2217/nnm-2019-0137
摘要
Lifelong systemic immunosuppression remains the biggest challenge in vascularized composite allotransplantation (VCA) due to the adverse effects it causes. Since VCA is a life-enhancing procedure as compared with solid organ transplant which is life-saving; one needs to weigh the benefits and risks carefully. Thus, there is a huge unmet clinical need to design biomaterial-based vehicles that can deliver drugs more efficiently, topically and locally to eliminate adverse effects of systemic immune suppression. This review discusses several biomaterial-based systems that have been carefully designed, conceived and attempted to make VCA a more patient compliant approach. Variety of promising preclinical studies has shown the feasibility of the approaches, and clinical trials are required to bridge the gap. Several challenges for the future and new approaches have been discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI